Affymetrix Inc. has announced the full commercial launch of the GeneChip® Human Gene 1.0 ST Array, the latest addition to its whole-transcript assay-based gene expression product family. The ...

Whole-genome microarray gene expression profiling has rapidly become the gold standard platform for retrospective prognostic and predictive gene discovery in human cancers, but currently depends on ...

Microarrays have been widely used for the analysis of gene expression, but the issue of reproducibility across platforms has yet to be fully resolved. To address this apparent problem, we compared ...

SANTA CLARA, Calif.--(BUSINESS WIRE)--Affymetrix Inc. (Nasdaq:AFFX) announced today that it has entered into a definitive agreement to acquire Panomics Inc., a privately held Fremont, Calif.-based ...

Genomatix Software GmbH today announced that it has achieved GeneChip-compatible TM status for several products with the Affymetrix Inc. (Nasdaq: AFFX) GeneChip® microarray platform and that it has ...

Offerings Now Encompass Multiplex and Parallel Analysis of Cells, Proteins, and Genes Affymetrix, best known for its pioneering work in commercializing microarrays for gene expression research since ...

SANTA CLARA, Calif.--(BUSINESS WIRE)-- Affymetrix, Inc. (NASDAQ:AFFX - News) today announced that the U.S. Food and Drug Administration has cleared the addition of new gene expression reagents as ...

Affymetrix Showcases Third-Party Microarray Analysis Software Like it or not, biologists have to deal increasingly in informatics as their experiments generate ever larger and more complex data sets.

SANTA CLARA, Calif. & POTSDAM, Germany--(BUSINESS WIRE)--Affymetrix, Inc. and Signature Diagnostics AG today announced that they have signed a Powered by Affymetrix™ (PbA) agreement. Under the ...

The R notebook stored in this repository contains the code used to process Affymetrix Yeast Genome 2.0 microarray data for the Almeida et al (2023) publication titled Physiological and molecular ...